The Asia Pacific Protein A Resin Market would witness market growth of 7.0% CAGR during the forecast period (2022-2028).
The Protein A affinity chromatography method is largely utilized in labs to obtain & purify immunoglobulins, like monoclonal antibody products & IgG. The procedure operates on the concept of the tying of particular antibodies to deactivate Protein A ligands. Throughout the assay, Protein A resin is connected to 4% agarose, following which the tying is optimized to attain an increased binding ability of immunoglobulins. Various factors regulate the dynamic binding ability of the resin to antibodies, like target antibody and flow rate.
Immunoprecipitation is an affinity purification method for antigens. In this method, the antibodies are disabled on the agarose resin exterior, which enables their efficient binding with particular antigens is there in the solution. Protein A Resin utilizes purified antibodies in a sandwich pattern to purify proteins, antigenic molecules, & complexes. Furthermore, it helps in precipitating antibodies from different complex mixtures.
Japan is an extremely industrialized country whose economy is mainly constructed on science & technology. In 2017, the nation had a more advanced technology supply throughout the world, with above 1,060 million engineers and scientists. In addition, the pharmaceutical industry and business enterprises recruited more than 586,000 technicians and researchers, nationwide. For several decades, Japan has been one of the world leaders in expending on patent applications, scientific publications, and R&D. It has been observed that the increase in the pharmaceutical sector. This development of the healthcare sector has increased the usage of protein A resins across the pharma and biopharma industry. This will result in the growth of protein A resin market in the upcoming years.
The China market dominated the Asia Pacific Protein A Resin Market by Country 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $142 million by 2028.The Japan market is estimated to grow a CAGR of 6.3% during (2022 - 2028). Additionally, The India market would experience a CAGR of 7.6% during (2022 - 2028).
Based on Product Type, the market is segmented into Agarose-based, Glass/Silica-based and Organic Polymer-based. Based on End Use, the market is segmented into Pharmaceutical & Biopharmaceutical Companies, Academic Research Institutes and Others. Based on Type, the market is segmented into Recombinant and Natural. Based on Application, the market is segmented into Antibody Purification and Immunoprecipitation. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Repligen Corporation, PerkinElmer, Inc, Thermo Fisher Scientific, Inc., Merck Millipore (Merck Group), Genscript Biotech Corporation, Agilent Technologies, Inc., Abcam plc, and Novasep Holdings SAS (Azulis Capital).
The Protein A affinity chromatography method is largely utilized in labs to obtain & purify immunoglobulins, like monoclonal antibody products & IgG. The procedure operates on the concept of the tying of particular antibodies to deactivate Protein A ligands. Throughout the assay, Protein A resin is connected to 4% agarose, following which the tying is optimized to attain an increased binding ability of immunoglobulins. Various factors regulate the dynamic binding ability of the resin to antibodies, like target antibody and flow rate.
Immunoprecipitation is an affinity purification method for antigens. In this method, the antibodies are disabled on the agarose resin exterior, which enables their efficient binding with particular antigens is there in the solution. Protein A Resin utilizes purified antibodies in a sandwich pattern to purify proteins, antigenic molecules, & complexes. Furthermore, it helps in precipitating antibodies from different complex mixtures.
Japan is an extremely industrialized country whose economy is mainly constructed on science & technology. In 2017, the nation had a more advanced technology supply throughout the world, with above 1,060 million engineers and scientists. In addition, the pharmaceutical industry and business enterprises recruited more than 586,000 technicians and researchers, nationwide. For several decades, Japan has been one of the world leaders in expending on patent applications, scientific publications, and R&D. It has been observed that the increase in the pharmaceutical sector. This development of the healthcare sector has increased the usage of protein A resins across the pharma and biopharma industry. This will result in the growth of protein A resin market in the upcoming years.
The China market dominated the Asia Pacific Protein A Resin Market by Country 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $142 million by 2028.The Japan market is estimated to grow a CAGR of 6.3% during (2022 - 2028). Additionally, The India market would experience a CAGR of 7.6% during (2022 - 2028).
Based on Product Type, the market is segmented into Agarose-based, Glass/Silica-based and Organic Polymer-based. Based on End Use, the market is segmented into Pharmaceutical & Biopharmaceutical Companies, Academic Research Institutes and Others. Based on Type, the market is segmented into Recombinant and Natural. Based on Application, the market is segmented into Antibody Purification and Immunoprecipitation. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Repligen Corporation, PerkinElmer, Inc, Thermo Fisher Scientific, Inc., Merck Millipore (Merck Group), Genscript Biotech Corporation, Agilent Technologies, Inc., Abcam plc, and Novasep Holdings SAS (Azulis Capital).
Scope of the Study
Market Segments Covered in the Report:
By Product Type
- Agarose-based
- Glass/Silica-based
- Organic Polymer-based
By End Use
- Pharmaceutical & Biopharmaceutical Companies
- Academic Research Institutes
- Others
By Type
- Recombinant
- Natural
By Application
- Antibody Purification
- Immunoprecipitation
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- General Electric (GE) Co. (GE Healthcare)
- Repligen Corporation
- PerkinElmer, Inc
- Thermo Fisher Scientific, Inc
- Merck Millipore (Merck Group)
- Genscript Biotech Corporation
- Agilent Technologies, Inc
- Abcam plc
- Novasep Holdings SAS (Azulis Capital)
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Protein A Resin Market, by Product Type
1.4.2 Asia Pacific Protein A Resin Market, by End Use
1.4.3 Asia Pacific Protein A Resin Market, by Type
1.4.4 Asia Pacific Protein A Resin Market, by Application
1.4.5 Asia Pacific Protein A Resin Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Protein A Resin Market
Chapter 4. Asia Pacific Protein A Resin Market by Product Type
4.1 Asia Pacific Agarose-based Market by Country
4.2 Asia Pacific Glass/Silica-based Market by Country
4.3 Asia Pacific Organic Polymer-based Market by Country
Chapter 5. Asia Pacific Protein A Resin Market by End-use
5.1 Asia Pacific Pharmaceutical & Biopharmaceutical Companies Market by Country
5.2 Asia Pacific Academic Research Institutes Market by Country
5.3 Asia Pacific Others Market by Country
Chapter 6. Asia Pacific Protein A Resin Market by Type
6.1 Asia Pacific Recombinant Market by Country
6.2 Asia Pacific Natural Market by Country
Chapter 7. Asia Pacific Protein A Resin Market by Application
7.1 Asia Pacific Antibody Purification Market by Country
7.2 Asia Pacific Immunoprecipitation Market by Country
Chapter 8. Asia Pacific Protein A Resin Market by Country
8.1 China Protein A Resin Market
8.1.1 China Protein A Resin Market by Product Type
8.1.2 China Protein A Resin Market by End-use
8.1.3 China Protein A Resin Market by Type
8.1.4 China Protein A Resin Market by Application
8.2 Japan Protein A Resin Market
8.2.1 Japan Protein A Resin Market by Product Type
8.2.2 Japan Protein A Resin Market by End-use
8.2.3 Japan Protein A Resin Market by Type
8.2.4 Japan Protein A Resin Market by Application
8.3 India Protein A Resin Market
8.3.1 India Protein A Resin Market by Product Type
8.3.2 India Protein A Resin Market by End-use
8.3.3 India Protein A Resin Market by Type
8.3.4 India Protein A Resin Market by Application
8.4 South Korea Protein A Resin Market
8.4.1 South Korea Protein A Resin Market by Product Type
8.4.2 South Korea Protein A Resin Market by End-use
8.4.3 South Korea Protein A Resin Market by Type
8.4.4 South Korea Protein A Resin Market by Application
8.5 Singapore Protein A Resin Market
8.5.1 Singapore Protein A Resin Market by Product Type
8.5.2 Singapore Protein A Resin Market by End-use
8.5.3 Singapore Protein A Resin Market by Type
8.5.4 Singapore Protein A Resin Market by Application
8.6 Malaysia Protein A Resin Market
8.6.1 Malaysia Protein A Resin Market by Product Type
8.6.2 Malaysia Protein A Resin Market by End-use
8.6.3 Malaysia Protein A Resin Market by Type
8.6.4 Malaysia Protein A Resin Market by Application
8.7 Rest of Asia Pacific Protein A Resin Market
8.7.1 Rest of Asia Pacific Protein A Resin Market by Product Type
8.7.2 Rest of Asia Pacific Protein A Resin Market by End-use
8.7.3 Rest of Asia Pacific Protein A Resin Market by Type
8.7.4 Rest of Asia Pacific Protein A Resin Market by Application
Chapter 9. Company Profiles
9.1 General Electric (GE) Co. (GE Healthcare)
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 SWOT Analysis
9.2 Repligen Corporation
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Regional Analysis
9.2.4 Research & Development Expenses
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.5.2 Acquisition and Mergers:
9.3 PerkinElmer, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Acquisition and Mergers:
9.4 Thermo Fisher Scientific, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.5 Bio-Rad Laboratories, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 Recent strategies and developments:
9.5.5.1 Product Launches and Product Expansions:
9.6 Merck Millipore (Merck Group)
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.7 Genscript Biotech Corporation
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Regional & Segmental Analysis
9.7.4 Research & Development Expenses
9.8 Agilent Technologies, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expense
9.9 Abcam plc
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expenses
9.10. Novasep Holdings SAS (Azulis Capital)
9.10.1 Company Overview
Companies Mentioned
- General Electric (GE) Co. (GE Healthcare)
- Repligen Corporation
- PerkinElmer, Inc
- Thermo Fisher Scientific, Inc.
- Merck Millipore (Merck Group)
- Genscript Biotech Corporation
- Agilent Technologies, Inc.
- Abcam plc
- Novasep Holdings SAS (Azulis Capital)
Methodology
LOADING...
